Group One Trading’s Ventyx Biosciences VTYX Stock Holding History

Group One Trading’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,200	Closed	-$246K	–	8867
2025 Q4	$246K	Buy	+27,200	New	+$203K	﹤0.01%	4196
2025 Q3	–	Sell	-5,000	Closed	-$10.7K	–	9240
2025 Q2	$10.7K	Sell	5,000 -3,200	-39%	-$5.17K	﹤0.01%	6677
2025 Q1	$9.43K	Sell	8,200 -15,800	-66%	-$27.1K	﹤0.01%	6298
2024 Q4	$52.6K	Sell	24,000 -4,500	-16%	-$10.2K	﹤0.01%	5016
2024 Q3	$62.1K	Sell	28,500 -13,600	-32%	-$31.3K	﹤0.01%	4504
2024 Q2	$97.3K	Buy	42,100 +36,000	+590%	+$150K	﹤0.01%	3983
2024 Q1	$33.5K	Sell	6,100 -644,700	-99%	-$2.95M	﹤0.01%	5036
2023 Q4	$1.61M	Buy	650,800 +650,100	+92,871%	+$6.17M	﹤0.01%	2051
2023 Q3	$24.3K	Sell	700 -5,300	-88%	-$183K	﹤0.01%	5735
2023 Q2	$197K	Buy	+6,000	New	+$207K	﹤0.01%	3941

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's VTYX Position: Q4 2025 in Review

Group One Trading sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 55,569 shares — an estimated $415K sold.

Group One Trading first reported a position in VTYX in Q4 2023 and held it in 8 quarters. The position peaked at $798K in Q4 2023. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

Group One Trading reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 55,569 Ventyx Biosciences shares in Q4 2025, an estimated $415K.
Group One Trading first reported a position in Ventyx Biosciences in Q4 2023 and held it in 8 quarters.
Group One Trading's Ventyx Biosciences position peaked at $798K in Q4 2023.
139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.